Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 69
Filtrer
1.
Cir Cir ; 92(3): 399-402, 2024.
Article de Anglais | MEDLINE | ID: mdl-38862120

RÉSUMÉ

Massive bleeding due to rupture of hypogastric artery pseudoaneurysm is an exceptional complication of colorectal anastomotic leakage. A 41-year-old woman with history of rectal cancer surgery, who debuted with massive rectorrhagia and hypovolemic shock due to rupture of a hypogastric artery pseudoaneurysm as a late complication of a colorectal anastomosis leak. The ruptured hypogastric artery pseudoaneurysm should be taken into account in the differential diagnosis of patients with massive rectorrhagia and history of colorectal anastomosis leak. Endovascular embolization is considered the first-line treatment.


La hemorragia masiva por rotura de un pseudoaneurisma de la arteria hipogástrica es una complicación muy rara de la fuga anastomótica colorrectal. Mujer de 41 años con antecedentes de cirugía por cáncer de recto, que debutó con un cuadro de rectorragias masivo y shock hipovolémico secundario a la rotura de un pseudoaneurisma de la arteria hipogástrica como complicación tardía de una fuga de la anastomosis colorrectal. La rotura de un pseudoaneurisma de la arteria hipogástrica se debe tener presente en el diagnostico diferencial de pacientes con rectorragia masiva y antecedentes de dehiscencia de anastomosis colorrectal. La embolización endovascular es actualmente el tratamiento de elección.


Sujet(s)
Désunion anastomotique , Faux anévrisme , Choc hémorragique , Humains , Faux anévrisme/étiologie , Femelle , Adulte , Désunion anastomotique/étiologie , Choc hémorragique/étiologie , Rupture d'anévrysme/chirurgie , Rectum/chirurgie , Tumeurs du rectum/chirurgie , Côlon/chirurgie , Côlon/vascularisation , Anastomose chirurgicale
2.
Ann Surg ; 280(2): 212-221, 2024 Aug 01.
Article de Anglais | MEDLINE | ID: mdl-38708880

RÉSUMÉ

OBJECTIVE: To determine the feasibility, efficacy, and safety of early cold stored platelet transfusion compared with standard care resuscitation in patients with hemorrhagic shock. BACKGROUND: Data demonstrating the safety and efficacy of early cold stored platelet transfusion are lacking following severe injury. METHODS: A phase 2, multicenter, randomized, open label, clinical trial was performed at 5 US trauma centers. Injured patients at risk of large volume blood transfusion and the need for hemorrhage control procedures were enrolled and randomized. The intervention was the early transfusion of a single apheresis cold stored platelet unit, stored for up to 14 days versus standard care resuscitation. The primary outcome was feasibility and the principal clinical outcome for efficacy and safety was 24-hour mortality. RESULTS: Mortality at 24 hours was 5.9% in patients who were randomized to early cold stored platelet transfusion compared with 10.2% in the standard care arm (difference, -4.3%; 95% CI, -12.8% to 3.5%; P =0.26). No significant differences were found for any of the prespecified ancillary outcomes. Rates of arterial and/or venous thromboembolism and adverse events did not differ across treatment groups. CONCLUSIONS AND RELEVANCE: In severely injured patients, early cold stored platelet transfusion is feasible, safe and did not result in a significant lower rate of 24-hour mortality. Early cold stored platelet transfusion did not result in a higher incidence of arterial and/or venous thrombotic complications or adverse events. The storage age of the cold stored platelet product was not associated with significant outcome differences. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT04667468.


Sujet(s)
Conservation de sang , Transfusion de plaquettes , Choc hémorragique , Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Choc hémorragique/thérapie , Choc hémorragique/étiologie , Conservation de sang/méthodes , Études de faisabilité , Plaies et blessures/thérapie , Plaies et blessures/complications , Résultat thérapeutique , Réanimation/méthodes , Basse température
3.
J Trauma Acute Care Surg ; 96(3): 499-509, 2024 Mar 01.
Article de Anglais | MEDLINE | ID: mdl-37478348

RÉSUMÉ

BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is gaining popularity worldwide for managing hypotensive trauma patients. Vascular access complications related to REBOA placement have been reported, with some cases resulting in permanent morbidity. We aim to capitalize on the increase in literature to further describe and estimate the incidence of REBOA-associated vascular access complications in adult trauma patients. METHODS: We searched Medline, EMBASE, Scopus, and CINAHL for studies reporting vascular access complications of REBOA in adult trauma patients from inception to October 14, 2021. Studies reporting data from adult trauma patients who underwent REBOA insertion were eligible. Exclusion criteria included patients 15 years and younger, nontrauma patients, non-REBOA use, non-vascular access complications and patient duplication. Study data was abstracted using the PRISMA checklist and verified independently by three reviewers. Meta-analysis of proportions was performed using a random effects model with Freeman-Turkey double-arcsine transformation. Post hoc meta-regression by year of publication, sheath-size, and geographic region was also performed. The incidence of vascular access complications from REBOA insertion was the primary outcome of interest. Subgroup analysis was performed by degree of bias, sheath size, technique of vascular access, provider specialty, geographical region, and publication year. RESULTS: Twenty-four articles were included in the systematic review and the meta-analysis, for a total of 675 trauma patients who underwent REBOA insertion. The incidence of vascular access complications was 8% (95% confidence interval, 5%-13%). In post hoc meta-regression adjusting for year of publication and geographic region, the use of a smaller (7-Fr) sheath was associated with a decreased incidence of vascular access complications (odds ratio, 0.87; 95% confidence interval, 0.75-0.99; p = 0.046; R 2 = 35%; I 2 = 48%). CONCLUSION: This study provides a benchmark for quality of care in terms of vascular access complications related to REBOA insertion in adult trauma patients. Smaller sheath size may be associated with a decrease in vascular access complications. LEVEL OF EVIDENCE: Systematic Review and Meta-Analysis; Level III.


Sujet(s)
Occlusion par ballonnet , Procédures endovasculaires , Choc hémorragique , Adulte , Humains , Études rétrospectives , Aorte/traumatismes , Réanimation/méthodes , Occlusion par ballonnet/effets indésirables , Occlusion par ballonnet/méthodes , Incidence , Procédures endovasculaires/effets indésirables , Procédures endovasculaires/méthodes , Choc hémorragique/étiologie , Choc hémorragique/thérapie , Choc hémorragique/épidémiologie
4.
Eur J Med Res ; 27(1): 202, 2022 Oct 17.
Article de Anglais | MEDLINE | ID: mdl-36253841

RÉSUMÉ

BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a damage control tool with a potential role in the hemodynamic resuscitation of severely ill patients in the civilian pre-hospital setting. REBOA ensures blood flow to vital organs by early proximal control of the source of bleeding. However, there is no consensus on the use of REBOA in the pre-hospital setting. This article aims to perform a systematic review of the literature about the feasibility, survival, indications, complications, and potential candidates for civilian pre-hospital REBOA. METHODS: A literature search was conducted using Medline, EMBASE, LILACS and Web of Science databases. Primary outcome variables included overall survival and feasibility. Secondary outcome variables included complications and potential candidates for endovascular occlusion. RESULTS: The search identified 8 articles. Five studies described the use of REBOA in pre-hospital settings, reporting a total of 47 patients in whom the procedure was attempted. Pre-hospital REBOA was feasible in 68-100% of trauma patients and 100% of non-traumatic patients with cardiac arrest. Survival rates and complications varied widely. Pre-hospital REBOA requires a coordinated and integrated emergency health care system with a well-trained and equipped team. The remaining three studies performed a retrospective analysis identifying 784 potential REBOA candidates. CONCLUSIONS: Pre-hospital REBOA could be a feasible intervention for a significant portion of severely ill patients in the civilian setting. However, the evidence is limited. The impact of pre-hospital REBOA should be assessed in future studies.


Sujet(s)
Occlusion par ballonnet , Procédures endovasculaires , Choc hémorragique , Aorte , Occlusion par ballonnet/méthodes , Procédures endovasculaires/effets indésirables , Procédures endovasculaires/méthodes , Hôpitaux , Humains , Réanimation/méthodes , Études rétrospectives , Choc hémorragique/étiologie , Choc hémorragique/thérapie
7.
Ann Surg ; 273(2): 358-364, 2021 02 01.
Article de Anglais | MEDLINE | ID: mdl-30998533

RÉSUMÉ

OBJECTIVE: The aim of this study was to determine whether prehospital blood products reduce 30-day mortality in patients at risk for hemorrhagic shock compared with crystalloid only resuscitation. SUMMARY OF BACKGROUND DATA: Hemorrhage is the primary cause of preventable death after injury. Large volume crystalloid resuscitation can be deleterious. The benefits of prehospital packed red blood cells (PRBCs), plasma, or transfusion of both products among trauma patients is unknown compared with crystalloid. METHODS: Secondary analysis of the multicenter PAMPer trial was performed on hypotensive injured patients from the scene. The trial randomized 27 helicopter bases to prehospital plasma or standard resuscitation. Standard resuscitation at the sites was equally divided between crystalloid and crystalloid + PRBC. This led to 4 prehospital resuscitation groups: crystalloid only; PRBC; plasma; and PRBC+plasma. Cox regression determined the association between resuscitation groups and risk-adjusted 30-day mortality. The dose effect of resuscitation fluids was also explored. RESULTS: Four hundred seven patients were included. PRBC+plasma had the greatest benefit [hazard ratio (HR) 0.38; 95% confidence interval (95% CI) 0.26-0.55, P < 0.001], followed by plasma (HR 0.57; 95% CI 0.36-0.91, P = 0.017) and PRBC (HR 0.68; 95% CI 0.49-0.95, P = 0.025) versus crystalloid only. Mortality was lower per-unit of PRBC (HR 0.69; 95% CI 0.52-0.92, p = 0.009) and plasma (HR 0.68; 95% CI 0.54-0.88, P = 0.003). Crystalloid volume was associated with increased mortality among patients receiving blood products (HR 1.65; 95% CI 1.17-2.32, P = 0.004). CONCLUSION: Patients receiving prehospital PRBC+plasma had the greatest mortality benefit. Crystalloid only had the worst survival. Patients with hemorrhagic shock should receive prehospital blood products when available, preferably PRBC+plasma. Prehospital whole blood may be ideal in this population.


Sujet(s)
Transfusion sanguine , Cristalloïdes/usage thérapeutique , Services des urgences médicales , Réanimation , Choc hémorragique/mortalité , Choc hémorragique/thérapie , Adulte , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Choc hémorragique/étiologie , Taux de survie , Plaies et blessures/complications , Plaies et blessures/mortalité , Plaies et blessures/thérapie
8.
Colomb. med ; 51(4): e4044511, Oct.-Dec. 2020. tab, graf
Article de Anglais | LILACS | ID: biblio-1154005

RÉSUMÉ

Abstract Hemorrhagic shock and its complications are a major cause of death among trauma patients. The management of hemorrhagic shock using a damage control resuscitation strategy has been shown to decrease mortality and improve patient outcomes. One of the components of damage control resuscitation is hemostatic resuscitation, which involves the replacement of lost blood volume with components such as packed red blood cells, fresh frozen plasma, cryoprecipitate, and platelets in a 1:1:1:1 ratio. However, this is a strategy that is not applicable in many parts of Latin America and other low-and-middle-income countries throughout the world, where there is a lack of well-equipped blood banks and an insufficient availability of blood products. To overcome these barriers, we propose the use of cold fresh whole blood for hemostatic resuscitation in exsanguinating patients. Over 6 years of experience in Ecuador has shown that resuscitation with cold fresh whole blood has similar outcomes and a similar safety profile compared to resuscitation with hemocomponents. Whole blood confers many advantages over component therapy including, but not limited to the transfusion of blood with a physiologic ratio of components, ease of transport and transfusion, less volume of anticoagulants and additives transfused to the patient, and exposure to fewer donors. Whole blood is a tool with reemerging potential that can be implemented in civilian trauma centers with optimal results and less technical demand.


Resumen El choque hemorrágico y sus complicaciones son la principal causa de muerte en los pacientes con trauma. La resucitación en control de daños ha demostrado una disminución en la mortalidad y mejoría en el manejo del paciente. La resucitación hemostática consiste en la recuperación del volumen con hemoderivados como glóbulos rojos, plasma, crioprecipitado y plaquetas, en proporciones de 1:1:1:1. Sin embargo, esta demanda de hemo componentes podría no aplicarse para toda Latinoamérica u otros países de medianos y bajos ingresos. Las principales barreras para la implementación de esta estrategia serían la escasa disponibilidad de bancos de sangre y de hemoderivados insuficientes para contar con un protocolo de transfusión masiva. Una propuesta para superar estas barreras es el uso de sangre total fresca fría para la resucitación hemostática de los pacientes exsanguinados. Ecuador ha sido pionero en la implementación de esta estrategia con una experiencia ya de seis años, en que han demostrado que la sangre total tiene ventajas sobre la terapia de hemo componentes incluyendo, pero no limitando, la trasfusión de sangre con una razón fisiológica de componentes, fácil transporte y transfusión, menor volumen de anticoagulantes y aditivos trasfundidos al paciente, y menor exposición a donantes. La sangre total es una herramienta con un potencial reemergente que puede ser implementado en centros de trauma civil con óptimos resultados y menor demanda técnica.


Sujet(s)
Humains , Réanimation/méthodes , Choc hémorragique/étiologie , Choc hémorragique/thérapie , Plaies et blessures/complications , Transfusion sanguine , Techniques d'hémostase , Score de gravité des lésions traumatiques
9.
Medwave ; 20(3): e7879, 2020 Apr 23.
Article de Espagnol | MEDLINE | ID: mdl-32343684

RÉSUMÉ

Trauma is the leading cause of death in the first four decades of life, responsible for 3.5 million deaths a year and carrying a high economic and social impact. Hemorrhagic shock is the consequence of injuries in these patients. Despite extensive knowledge about its pathophysiology and many replacement drugs and therapies, resuscitation of the intravascular volume sometimes is insufficient and ineffective. Hemorrhagic shock, resulting in macro and microvascular changes that favor the development of anaerobic metabolism, is associated with multiple complications that can lead to the demise of the patient. The purpose of this article is to describe the essential aspects that should be taken into account during the resuscitation of the intravascular volume of multiple trauma patients. We conducted a search and review of the available literature on the resuscitation of trauma patients. Reference searches were conducted in the MEDLINE/PubMed, Cumed, SciELO, EBSCO, Hinari, Cochrane databases. We reviewed the historical evolution of volume replacement in the polytrauma patient, endothelial glycocalyx, changes in the Starling law paradigm, goal-guided resuscitation, the different fluids used during resuscitation, monitoring, and the concepts of damage control resuscitation and damage control surgery.


El trauma es la principal causa de muerte en las primeras cuatro décadas de la vida, responsable de 3,5 millones de muertes al año con un alto impacto económico y social. El estado de shock hemorrágico es la consecuencia de las lesiones en estos pacientes, donde a pesar de un amplio conocimiento de su fisiopatología e innumerables fármacos y terapias de reemplazo, a menudo es insuficiente e ineficaz para resucitar su volumen intravascular. Esta entidad produce alteraciones macro y microvasculares, que favorecen el desarrollo del metabolismo anaerobio. Se encuentra asociado a múltiples complicaciones que pueden derivar en la muerte del paciente. El objetivo de este trabajo es describir aspectos esenciales para tener en cuenta durante la reanimación del volumen intravascular de pacientes politraumatizados. Se realizó una búsqueda y revisión de la literatura disponible sobre reanimación del paciente politraumatizado. Se efectuaron búsquedas de referencias en las bases de datos MEDLINE/PubMed, Cumed, SciELO, EBSCO, Hinari, Cochrane. Se revisaron aspectos como la evolución histórica del reemplazo de volumen en el paciente politraumatizado, el glicocalix endotelial, los cambios en el paradigma de las leyes de Starling, la reanimación guiada por objetivos, los diferentes líquidos que se utilizan durante la reanimación, el monitoreo de estos y los conceptos de reanimación y cirugía de control de daños.


Sujet(s)
Polytraumatisme/thérapie , Réanimation/méthodes , Choc hémorragique/thérapie , Traitement par apport liquidien/méthodes , Humains , Polytraumatisme/complications , Choc hémorragique/étiologie
10.
Colomb Med (Cali) ; 51(4): e4044511, 2020 Dec 30.
Article de Anglais | MEDLINE | ID: mdl-33795899

RÉSUMÉ

Hemorrhagic shock and its complications are a major cause of death among trauma patients. The management of hemorrhagic shock using a damage control resuscitation strategy has been shown to decrease mortality and improve patient outcomes. One of the components of damage control resuscitation is hemostatic resuscitation, which involves the replacement of lost blood volume with components such as packed red blood cells, fresh frozen plasma, cryoprecipitate, and platelets in a 1:1:1:1 ratio. However, this is a strategy that is not applicable in many parts of Latin America and other low-and-middle-income countries throughout the world, where there is a lack of well-equipped blood banks and an insufficient availability of blood products. To overcome these barriers, we propose the use of cold fresh whole blood for hemostatic resuscitation in exsanguinating patients. Over 6 years of experience in Ecuador has shown that resuscitation with cold fresh whole blood has similar outcomes and a similar safety profile compared to resuscitation with hemocomponents. Whole blood confers many advantages over component therapy including, but not limited to the transfusion of blood with a physiologic ratio of components, ease of transport and transfusion, less volume of anticoagulants and additives transfused to the patient, and exposure to fewer donors. Whole blood is a tool with reemerging potential that can be implemented in civilian trauma centers with optimal results and less technical demand.


El choque hemorrágico y sus complicaciones son la principal causa de muerte en los pacientes con trauma. La resucitación en control de daños ha demostrado una disminución en la mortalidad y mejoría en el manejo del paciente. La resucitación hemostática consiste en la recuperación del volumen con hemoderivados como glóbulos rojos, plasma, crioprecipitado y plaquetas, en proporciones de 1:1:1:1. Sin embargo, esta demanda de hemo componentes podría no aplicarse para toda Latinoamérica u otros países de medianos y bajos ingresos. Las principales barreras para la implementación de esta estrategia serían la escasa disponibilidad de bancos de sangre y de hemoderivados insuficientes para contar con un protocolo de transfusión masiva. Una propuesta para superar estas barreras es el uso de sangre total fresca fría para la resucitación hemostática de los pacientes exsanguinados. Ecuador ha sido pionero en la implementación de esta estrategia con una experiencia ya de seis años, en que han demostrado que la sangre total tiene ventajas sobre la terapia de hemo componentes incluyendo, pero no limitando, la trasfusión de sangre con una razón fisiológica de componentes, fácil transporte y transfusión, menor volumen de anticoagulantes y aditivos trasfundidos al paciente, y menor exposición a donantes. La sangre total es una herramienta con un potencial reemergente que puede ser implementado en centros de trauma civil con óptimos resultados y menor demanda técnica.


Sujet(s)
Transfusion sanguine , Techniques d'hémostase , Réanimation/méthodes , Choc hémorragique/étiologie , Choc hémorragique/thérapie , Plaies et blessures/complications , Humains , Score de gravité des lésions traumatiques
11.
Rev. chil. anest ; 48(3): 262-269, 2019. tab
Article de Espagnol | LILACS | ID: biblio-1452020

RÉSUMÉ

In the world, traumatic pathology continues to be a problem of great magnitude, from the point of view of public health. Today, the volumemic resuscitation in hypovolemic hemorrhagic shock is still controversial; a new alternative in volemic resuscitation is the hemostatic resuscitation that consists of the rapid use of whole blood or of the administration of the concentrate of erythrocytes (CE), fresh frozen plasma (PFC) and platelet concentrate (CP), with a fixed ratio between the products. OBJECTIVE: Clinical case presentation, as well as review of the published literature on hemostatic resuscitation in patients with hemorrhagic hypovolemic shock. MATERIAL AND METHODS: We present the case of a female patient of 16 years of age with penetrating injuries in the neck, thorax and abdomen; management and evolution in the operating room, intensive care unit until discharge. RESULTS: The adequate initial resuscitation in the patient with hemorrhagic hypovolemic shock has been shown to improve their survival, so that nowadays the application of new alternatives in resuscitation; As is the hemostatic resuscitation, they have yielded better results in the patient's prognosis. CONCLUSIONS: Trauma remains one of the main causes of admission to hospital units, with the young population being the most vulnerable due to car accidents. Strategies in improving the time of transfer from the accident site to the hospital unit, its definitive management in the operating room (if required) and the use of new alternatives in the management of hemorrhagic hypovolemic shock; such as hemostatic resuscitation, and the administration of pro-hemostatic drugs, are of great importance in the evolution and prognosis of the patient.


En el mundo, la patología traumática continúa siendo un problema de gran magnitud, desde el punto de vista de salud pública. Hoy en día la resucitación volémica en el choque hemorrágico hipovolémico todavía es controversial; una nueva alternativa en la resucitación volemica es la resucitación hemostática que consiste en el uso rápido de sangre total o de la administración del concentrado de Eritrocitos (CE), Plasma Fresco Congelado (PFC) y Concentrado de Plaquetas (CP), con una razón fija entre los productos. OBJETIVO: Presentación de caso clínico, así como revisión de la literatura publicada sobre resucitación hemostática en el paciente con choque hipovolémico hemorrágico. MATERIAL Y MÉTODOS: Se presenta el caso de paciente femenino de 16 años de edad con lesiones penetrantes en cuello, tórax y abdomen; manejo y evolución en sala de operaciones, unidad de cuidados intensivos hasta su egreso. RESULTADOS: La adecuada resucitación inicial en el paciente con choque hipovolémico hemorrágico ha demostrado mejorar su sobrevida, por lo que hoy en día la aplicación de nuevas alternativas en la reanimación; como es la resucitación hemostática, han arrojado mejores resultados en el pronóstico del paciente. CONCLUSIONES: El trauma sigue siendo una de las principales causas de ingreso a las unidades hospitalarias, siendo la población joven la más vulnerable por accidentes automovilísticos. Las estrategias en la mejora del tiempo de traslado del lugar del accidente hasta la unidad hospitalaria, su manejo definitivo en sala de quirófano (si así lo requiere) y el uso de nuevas alternativas en manejo del choque hipovolémico hemorrágico; como es la resucitación hemostática, y la ministración de fármacos pro hemostáticos, resultan de gran importancia en la evolución y pronóstico del paciente.


Sujet(s)
Humains , Femelle , Adolescent , Réanimation/méthodes , Choc hémorragique/thérapie , Plaies pénétrantes/complications , Choc hémorragique/étiologie , Plaies pénétrantes/thérapie , Érythrocytes , Plasma riche en plaquettes
12.
São Paulo med. j ; São Paulo med. j;136(5): 488-491, Sept.-Oct. 2018. tab, graf
Article de Anglais | LILACS | ID: biblio-979380

RÉSUMÉ

ABSTRACT CONTEXT: Aneurysms of the gastroepiploic arteries are seen only rarely. They are usually diagnosed during autopsy or laparotomy in patients with hemodynamic instability. Although the operation to treat this condition is relatively easy, delay in making the diagnosis affects the course of the disease. Case Report: A 57-year-old woman was admitted to the emergency department with abdominal pain and unconsciousness. A computed tomography scan showed extravasation of contrast agent at the headcorpus junction of the pancreas, and the patient underwent exploratory laparotomy under general anesthesia. During laparotomy, aneurysmatic rupture of the right gastroepiploic artery was detected. Control over bleeding was achieved by ligating the right gastroepiploic artery at its origin. The aneurysm was also resected and sent for pathological examination. CONCLUSION: Especially in cases of unidentified shock, splanchnic artery aneurysms should be kept in mind. Moreover, in the light of the data in the literature, the possibility of death should be taken into account seriously and, if feasible, prophylactic aneurysmectomy should be performed.


Sujet(s)
Humains , Femelle , Adulte d'âge moyen , Choc hémorragique/étiologie , Rupture d'anévrysme/complications , Artère gastro-omentale/chirurgie , Artère gastro-omentale/imagerie diagnostique , Rupture spontanée/chirurgie , Rupture spontanée/complications , Rupture spontanée/imagerie diagnostique , Choc hémorragique/chirurgie , Tomodensitométrie/méthodes , Douleur abdominale/étiologie , Rupture d'anévrysme/chirurgie , Rupture d'anévrysme/imagerie diagnostique , Laparotomie/méthodes
13.
Cochrane Database Syst Rev ; 6: CD011664, 2018 06 13.
Article de Anglais | MEDLINE | ID: mdl-29897100

RÉSUMÉ

BACKGROUND: An abdominal aortic aneurysm (AAA) is the pathological enlargement of the aorta and can develop in both men and women. Progressive aneurysm enlargement can lead to rupture. The rupture of an AAA is frequently fatal and accounts for the death from haemorrhagic shock of at least 45 people per 100,000 population. The outcome of people with ruptured AAA varies among countries and healthcare systems, with mortality ranging from 53% to 90%. Definitive treatment for ruptured AAA includes open surgery or endovascular repair. The management of haemorrhagic shock is crucial for the person's outcome and aims to restore organ perfusion and systolic blood pressure above 100 mmHg through immediate and aggressive fluid replacement. This rapid fluid replacement is known as the normotensive resuscitation strategy. However, evidence suggests that infusing large volumes of cold fluid causes dilutional and hypothermic coagulopathy. The association of these factors may exacerbate bleeding, resulting in a 'lethal triad' of hypothermia, acidaemia, and coagulopathy. An alternative to the normotensive resuscitation strategy is the controlled (permissive) hypotension resuscitation strategy, with a target systolic blood pressure of 50 mmHg to 100 mmHg. The principle of controlled or hypotensive resuscitation has been used in some management protocols for endovascular repair of ruptured AAA. It may be beneficial in preventing blood loss by avoiding the clot disruption caused by the rapid increase in systolic blood pressure; avoiding dilution of clotting factors, platelets and fibrinogen; and by avoiding the temperature decrease that inhibits enzyme activity involved in platelet and clotting factor function. This is an update of a review first published in 2016. OBJECTIVES: To compare the effects of controlled (permissive) hypotension resuscitation and normotensive resuscitation strategies for people with ruptured AAA. SEARCH METHODS: The Cochrane Vascular Information Specialist searched the Specialised Register (August 2017), the Cochrane Register of Studies (CENTRAL (2017, Issue 7)) and EMBASE (August 2017). The Cochrane Vascular Information Specialist also searched clinical trials databases (August 2017) for details of ongoing or unpublished studies. SELECTION CRITERIA: We sought all published and unpublished randomised controlled trial (RCTs) that compared controlled hypotension and normotensive resuscitation strategies for the management of shock in patients with ruptured abdominal aortic aneurysms. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed identified studies for potential inclusion in the review. We used standard methodological procedures in accordance with the Cochrane Handbook for Systematic Review of Interventions. MAIN RESULTS: We identified no RCTs that met the inclusion criteria. AUTHORS' CONCLUSIONS: We found no RCTs that compared controlled hypotension and normotensive resuscitation strategies in the management of haemorrhagic shock in patients with ruptured abdominal aortic aneurysm that assessed mortality, presence of coagulopathy, intensive care unit length of stay, and the presence of myocardial infarct and renal failure. High quality studies that evaluate the best strategy for managing haemorrhagic shock in ruptured abdominal aortic aneurysms are required.


Sujet(s)
Anévrysme de l'aorte abdominale/complications , Rupture aortique/complications , Pression sanguine , Hypotension contrôlée , Réanimation/méthodes , Choc hémorragique/thérapie , Humains , Choc hémorragique/étiologie , Systole
14.
Eur J Trauma Emerg Surg ; 44(4): 527-533, 2018 Aug.
Article de Anglais | MEDLINE | ID: mdl-29572730

RÉSUMÉ

Current literature shows the association of post-intubation hypotension and increased odds of mortality in critically ill non-trauma and trauma populations. However, there is a lack of research on potential interventions that can prevent or ameliorate the consequences of endotracheal intubation and thus improve the prognosis of trauma patients with post-intubation hypotension. This review paper hypothesizes that the deployment of REBOA among trauma patients with PIH, by its physiologic effects, will reduce the odds of mortality in this population. The objective of this paper is to review the current literature on REBOA and post-intubation hypotension, and, furthermore, to provide a rational hypothesis on the potential role of REBOA in severely injured patients with post-intubation hypotension.


Sujet(s)
Aorte , Occlusion par ballonnet/méthodes , Hypotension artérielle/étiologie , Hypotension artérielle/prévention et contrôle , Intubation trachéale/effets indésirables , Choc hémorragique/étiologie , Choc hémorragique/prévention et contrôle , Plaies et blessures/complications , Hémodynamique , Humains , Réanimation , Analyse de survie
15.
Sao Paulo Med J ; 136(5): 488-491, 2018.
Article de Anglais | MEDLINE | ID: mdl-28832810

RÉSUMÉ

CONTEXT: Aneurysms of the gastroepiploic arteries are seen only rarely. They are usually diagnosed during autopsy or laparotomy in patients with hemodynamic instability. Although the operation to treat this condition is relatively easy, delay in making the diagnosis affects the course of the disease. CASE REPORT: A 57-year-old woman was admitted to the emergency department with abdominal pain and unconsciousness. A computed tomography scan showed extravasation of contrast agent at the headcorpus junction of the pancreas, and the patient underwent exploratory laparotomy under general anesthesia. During laparotomy, aneurysmatic rupture of the right gastroepiploic artery was detected. Control over bleeding was achieved by ligating the right gastroepiploic artery at its origin. The aneurysm was also resected and sent for pathological examination. CONCLUSION: Especially in cases of unidentified shock, splanchnic artery aneurysms should be kept in mind. Moreover, in the light of the data in the literature, the possibility of death should be taken into account seriously and, if feasible, prophylactic aneurysmectomy should be performed.


Sujet(s)
Rupture d'anévrysme/complications , Artère gastro-omentale , Choc hémorragique/étiologie , Douleur abdominale/étiologie , Rupture d'anévrysme/imagerie diagnostique , Rupture d'anévrysme/chirurgie , Femelle , Artère gastro-omentale/imagerie diagnostique , Artère gastro-omentale/chirurgie , Humains , Laparotomie/méthodes , Adulte d'âge moyen , Rupture spontanée/complications , Rupture spontanée/imagerie diagnostique , Rupture spontanée/chirurgie , Choc hémorragique/chirurgie , Tomodensitométrie/méthodes
16.
Rev Med Inst Mex Seguro Soc ; 54(6): 787-792, 2016.
Article de Espagnol | MEDLINE | ID: mdl-27819791

RÉSUMÉ

BACKGROUND: An ectopic pregnancy happens when a fertilized egg attaches somewhere outside the endometrial surface. This sort of pregnancy has an estimated incidence of 1.6 to 2 each 100 births. The main objective was to expose the effective answer of a Rapid Response Team in a case of ruptured cervical ectopic pregnancy. We also describe a clinical case of this sort of pregnancy. CLINICAL CASE: 37-year-old female with a two-month history of amenorrhea. The patient entered the Labor & Delivery department with hypovolemic shock secondary to vaginal bleeding. The Código Mater (Mater Code) was activated and the Rapid Response Team arrived to the L&D department. This team performed pelvic examination and detected tissue in cervix with mild bleeding. The pelvic ultrasound displayed the presence of gas and the endometrium status was normal (no gestational sac was detected). The immunologic test for pregnancy was positive. It was diagnosed cervical ectopic pregnancy and hypovolemic shock. CONCLUSION: Providing timely access to care with standardized criteria by interdisciplinary teams in all the cases of obstetric emergency avoids maternal deaths related to obstetric hemorrhage.


Introducción: el embarazo ectópico es la implantación y nidación del huevo fertilizado fuera de la superficie endometrial. Se estima que su incidencia va de 1.6 a 2 embarazos ectópicos por cada 100 nacimientos. El objetivo fue exponer la efectividad de un equipo de respuesta inmediata (ERI) en un caso de embarazo ectópico cervical. Asimismo, se expone un caso clínico de embarazo ectópico. Caso clínico: mujer de 37 años de edad, con antecedente de retraso menstrual de dos meses. Ingresó a Tococirugía con choque hipovolémico secundario a sangrado transvaginal. Se activó Código Mater y acudió el equipo de respuesta inmediata (ERI), que hizo tacto vaginal bimanual y detectó abundante tejido en cérvix con sangrado moderado y rastreo ultrasonográfico, el cual refirió abundante gas en cérvix y endometrio normal (no se observó saco gestacional). La prueba inmunológica de embarazo fue positiva. Se diagnosticó embarazo ectópico cervical y choque hipovolémico. Conclusión: proporcionar atención oportuna, de calidad por equipos interdisciplinarios, con criterios uniformes, en todos los casos de emergencia obstétrica evita la muerte de la paciente por hemorragia obstétrica.


Sujet(s)
Services des urgences médicales , Grossesse extra-utérine/diagnostic , Adulte , Col de l'utérus , Femelle , Humains , Grossesse , Grossesse extra-utérine/thérapie , Rupture spontanée/diagnostic , Rupture spontanée/thérapie , Choc hémorragique/étiologie , Choc hémorragique/thérapie
17.
Cochrane Database Syst Rev ; (5): CD011664, 2016 May 13.
Article de Anglais | MEDLINE | ID: mdl-27176127

RÉSUMÉ

BACKGROUND: An abdominal aortic aneurysm (AAA) is the pathological enlargement of the aorta and can develop in both men and women. Progressive aneurysm enlargement can lead to rupture. The rupture of an AAA is frequently fatal and accounts for the death from haemorrhagic shock of at least 45 people per 100,000 population. The outcome of people with ruptured AAA varies among countries and healthcare systems, with mortality ranging from 53% to 90%. Definitive treatment for ruptured AAA includes open surgery or endovascular repair. The management of haemorrhagic shock is crucial for the person's outcome and aims to restore organ perfusion and systolic blood pressure above 100 mm Hg through immediate and aggressive fluid replacement. This rapid fluid replacement is known as the normotensive resuscitation strategy. However, evidence suggests that infusing large volumes of cold fluid causes dilutional and hypothermic coagulopathy. The association of these factors may exacerbate bleeding, resulting in a 'lethal triad' of hypothermia, acidaemia, and coagulopathy. An alternative to the normotensive resuscitation strategy is the controlled (permissive) hypotension resuscitation strategy, with a target systolic blood pressure of 50 to 100 mm Hg. The principle of controlled or hypotensive resuscitation has been used in some management protocols for endovascular repair of ruptured AAA. It may be beneficial in preventing blood loss by avoiding the clot disruption caused by the rapid increase in systolic blood pressure; avoiding dilution of clotting factors, platelets and fibrinogen; and by avoiding the temperature decrease that inhibits enzyme activity involved in platelet and clotting factor function. OBJECTIVES: To compare the effects of controlled (permissive) hypotension resuscitation and normotensive resuscitation strategies for people with ruptured AAA. SEARCH METHODS: The Cochrane Vascular Information Specialist searched the Specialised Register (April 2016) and the Cochrane Register of Studies (CENTRAL (2016, Issue 3)). Clinical trials databases were searched (April 2016) for details of ongoing or unpublished studies. SELECTION CRITERIA: We sought all published and unpublished randomised controlled trial (RCTs) that compared controlled hypotension and normotensive resuscitation strategies for the management of shock in patients with ruptured abdominal aortic aneurysms. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed identified studies for potential inclusion in the review. We used standard methodological procedures in accordance with the Cochrane Handbook for Systematic Review of Interventions. MAIN RESULTS: We identified no RCTs that met the inclusion criteria. AUTHORS' CONCLUSIONS: We found no RCTs that compared controlled hypotension and normotensive resuscitation strategies in the management of haemorrhagic shock in patients with ruptured abdominal aortic aneurysm that assessed mortality, presence of coagulopathy, intensive care unit length of stay, and the presence of myocardial infarct and renal failure. High quality studies that evaluate the best strategy for managing haemorrhagic shock in ruptured abdominal aortic aneurysms are required.


Sujet(s)
Anévrysme de l'aorte abdominale/complications , Rupture aortique/complications , Pression sanguine , Hypotension contrôlée , Réanimation/méthodes , Choc hémorragique/thérapie , Humains , Choc hémorragique/étiologie
18.
Curr Opin Anaesthesiol ; 29(2): 229-33, 2016 Apr.
Article de Anglais | MEDLINE | ID: mdl-26934280

RÉSUMÉ

PURPOSE OF REVIEW: Bleeding is still a major cause of death in trauma patients. Damage control surgery is a strategy that aims to control bleeding and avoid secondary contamination of the cavity. This article checks the principles and indications of damage control surgery, bleeding management, and the role of the anesthesiologist in trauma context. The efficient treatment of severe trauma and exsanguinated patients includes a surgical approach to the patient performed as quickly as possible. Volemic resuscitation, hemostatic transfusion, prevention and/or treatment of coagulopathy, hypothermia, and acidosis are strategies that reduce bleeding, as well as permissive hypotension. RECENT FINDINGS: Specialized literature shows us that the adoption of all of these principles along with reduced surgical time has led to a broader concept called damage control resuscitation. SUMMARY: Damage control resuscitation is a treatment strategy in which the recovery of physiological variables is initially prioritized over anatomical variables and can be required in severe trauma patients.


Sujet(s)
Troubles de l'hémostase et de la coagulation/thérapie , Facteurs de la coagulation sanguine/métabolisme , Choc hémorragique/thérapie , Plaies et blessures/chirurgie , Acidose/métabolisme , Anesthésiologistes , Troubles de l'hémostase et de la coagulation/prévention et contrôle , Transfusion sanguine , Humains , Hypotension contrôlée , Hypothermie/métabolisme , Choc hémorragique/étiologie , Plaies et blessures/complications
19.
Rev Col Bras Cir ; 42(4): 273-8, 2015.
Article de Anglais, Portugais | MEDLINE | ID: mdl-26517804

RÉSUMÉ

Trauma is one of the world's leading causes of death within the first 40 years of life and thus a significant health problem. Trauma accounts for nearly a third of the lost years of productive life before 65 years of age and is associated with infection, hemorrhagic shock, reperfusion syndrome, and inflammation. The control of hemorrhage, coagulopathy, optimal use of blood products, balancing hypo and hyperperfusion, and hemostatic resuscitation improve survival in cases of trauma with massive hemorrhage. This review discusses inflammation in the context of trauma-associated hemorrhagic shock. When one considers the known immunomodulatory effects of traumatic injury, allogeneic blood transfusion, and the overlap between patient populations, it is surprising that so few studies have assessed their combined effects on immune function. We also discuss the relative benefits of curbing inflammation rather than attempting to prevent it.


Sujet(s)
Inflammation/étiologie , Inflammation/thérapie , Choc hémorragique/complications , Plaies et blessures/complications , Humains , Guides de bonnes pratiques cliniques comme sujet , Choc hémorragique/étiologie , Choc hémorragique/immunologie , Syndrome de réponse inflammatoire généralisée/étiologie , Plaies et blessures/immunologie
20.
Cir Cir ; 83(6): 506-9, 2015.
Article de Espagnol | MEDLINE | ID: mdl-26319688

RÉSUMÉ

BACKGROUND: Even in expert hands, there can be serious complications when performing an endoscopic retrograde cholangiopancreatography. The most frequent complications are pancreatitis, cholangitis, bleeding, perforation, and acute cholecystitis. The hepatic subcapsular haematoma is a rare complication, with few cases described worldwide. OBJECTIVE: A case is presented of an extremely rare complication of endoscopic retrograde cholangiopancreatography, which required surgical treatment for its resolution without success. This is second case of mortality reported in the literature. CLINICAL CASE: Female patient of 30 years old, with indication for endoscopic retrograde cholangiopancreatography due to benign strictures. A hydro-pneumatic dilation and stent placement of 2 gauge 10 fr was performed. She presented abdominal pain after the procedure and significant decline in haemoglobin with no evidence of haemodynamic instability so an abdominal tomography scan was performed, showing no evidence of liver injury. The patient was haemodynamic unstable within 72 h. A laparotomy was required for damage control, with fatal outcome in the intensive care unit due to multiple organ failure. CONCLUSION: Subcapsular hepatic haematoma after endoscopic retrograde cholangiopancreatography is a rare complication, with few cases reported in the literature. Treatment described in the literature is conservative, resulting in a satisfactory resolution.


Sujet(s)
Cholangiopancréatographie rétrograde endoscopique/effets indésirables , Hématome/chirurgie , Foie/chirurgie , Complications postopératoires/chirurgie , Abdomen aigu/étiologie , Adulte , Côlon/vascularisation , Conduit cholédoque/anatomopathologie , Conduit cholédoque/chirurgie , Maladies du cholédoque/chirurgie , Sténose pathologique , Faux négatifs , Issue fatale , Femelle , Hématome/étiologie , Hémopéritoine/étiologie , Humains , Ischémie/étiologie , Laparotomie , Foie/traumatismes , Défaillance multiviscérale/étiologie , Complications postopératoires/étiologie , Choc hémorragique/étiologie , Endoprothèses , Tomodensitométrie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE